How Current Cost-Effectiveness Analyses Distort Drug Development Priorities
In the latest post in our ongoing series with Health [...]
IVI MEMBER SPOTLIGHT: Danny van Leeuwen
This year we are pleased to welcome Danny [...]
Bolstering Our Ability To Value Health Technology: A Few Less-Considered Issues
AcademyHealth’s Michael E. Gluck authors the next in the IVI [...]
Fair Prices Should Lead To Fair Access: Why Is The Grand Bargain So Hard?
In a new post in our ongoing blog series with [...]
The US Should Change Payment To Make Health Care More Equitable
The Health Affairs series continues with a post by [...]